Evidence map›Paper›PMID 34484867›Full record

ArticleMolecular therapy. Nucleic acids2021

Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in

Jakob Frimodt-Møller, Andreas Koulouktsis, Godefroid Charbon, Marit Otterlei, Peter E Nielsen, Anders Løbner-Olesen

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Activation of multiple stress responses inFrontiers in microbiology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Effects of LPS Composition inFrontiers in microbiology · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jakob Frimodt-MøllerDepartment of Biology, Center for Peptide-Based Antibiotics, University of Copenhagen, Ole Maaløes vej 5, 2200 Copenhagen N, Denmark.
Andreas KoulouktsisDepartment of Biology, Center for Peptide-Based Antibiotics, University of Copenhagen, Ole Maaløes vej 5, 2200 Copenhagen N, Denmark.
Godefroid CharbonDepartment of Biology, Center for Peptide-Based Antibiotics, University of Copenhagen, Ole Maaløes vej 5, 2200 Copenhagen N, Denmark.
Marit OtterleiDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, NO-7489 Trondheim, Norway.
Peter E NielsenDepartment of Cellular and Molecular Medicine, Center for Peptide-Based Antibiotics, The Panum Institute, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Anders Løbner-OlesenDepartment of Biology, Center for Peptide-Based Antibiotics, University of Copenhagen, Ole Maaløes vej 5, 2200 Copenhagen N, Denmark.
University of Copenhagen · DKNorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-penetrating peptides (CPPs) are increasingly used for cellular drug delivery in both pro- and eukaryotic cells, and oligoarginines have attracted special attention. How arginine-rich CPPs translocate across the cell envelope, particularly for prokaryotes, is still unknown. Arginine-rich CPPs efficiently deliver antimicrobial peptide nucleic acid (PNA) to its intracellular mRNA target in bacteria. We show that resistance to PNA conjugated to an arginine-rich CPP in

Indexed as

aminoglycosidesarginine-rich cell-penetrating peptidesCpx responseinner membranepeptide nucleic acids

Identifiers

PMID34484867
PMCPMC8403718
OpenAlexW3174667889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.